Overview

The Effect of Medical Grade Honey Formulation (L-Mesitran) Administration on Recurrent Vulvovaginal Candidiasis Symptoms

Status:
Recruiting
Trial end date:
2027-04-22
Target enrollment:
Participant gender:
Summary
The aim of the study is to investigate the efficacy of Fluconazol versus L-Mesitran in the treatment of patients with recurrent vulvovaginal candidiasis. Vaginal swabs will be analyzed after 1, 6 and 12 months. The study ends after 252 included patients completed the study.
Phase:
Phase 3
Details
Lead Sponsor:
Maastricht University Medical Center
Collaborator:
Zuyderland Medical Centre
Treatments:
Fluconazole